Strategic Licensing Partners Propel Labs' history of asset divestitures with major players points to a potential licensing or co-development path for niche bio-instrumentation. Position the company as a nimble partner for joint development or IP licensing to scale specialized technologies such as cell sorting or analysis modules.

Academic Outreach Target universities, research centers, and mid-sized biotech firms with grant pipelines and limited R&D bandwidth. Emphasize rapid delivery and customer-focused product iteration to convert inquiries into pilots or paid engagements.

Niche Flow Cytometry Leverage expertise in cell sorting and flow cytometry assets to pursue labs seeking advanced sorting and analysis capabilities. Propose modular instruments or add-on components that complement existing cytometry platforms.

Customization & Prototyping Offer contract R&D, customization, and white-label tool development to startups and CROs needing tailored instrumentation. Highlight speed to market and iterative design processes to differentiate Propel Labs.

Regional Partnerships Expand go-to-market through regional distributors and system integrators, leveraging any past EMEA exposure to identify partners in Europe and APAC. Align with government and academic procurement channels to broaden reach.